Assort Health Raises $120M Series C at $1.2B Valuation

Assort Health, based in San Francisco, California, is a software company providing an AI agents platform for the patient journey. The company announced a $120 million Series C funding round, bringing its total funding raised to date to more than $222 million.

Investors

The funding round was led by Menlo Ventures, with participation from Lightspeed Venture Partners, Felicis, First Round Capital, Chemistry, Joe Montana, Tau Ventures, and Quiet Capital.

Assort Health Use of Funds

The company intends to use the new capital to continue scaling its AI-powered patient access platform and its proprietary AI model, Synapse, across a broader range of health systems and academic medical centers.

About Assort Health

Founded by Jon Wang and Jeffery Liu, Assort Health provides an AI agent platform that automates patient interactions, including scheduling, intake, referrals, and document processing. The platform is designed to integrate with major EHR systems to streamline administrative workflows for healthcare providers.

Funding Details

Company Website: https://assorthealth.com

Company: Assort Health
Raised: $120M
Round: Series C
Funding Date: June 24, 2026
Lead Investor: Menlo Ventures
Additional Investors: Lightspeed Venture Partners, Felicis, First Round Capital, Chemistry, Joe Montana, Tau Ventures, Quiet Capital
Company Website: https://assorthealth.com
Software Category: Healthcare AI
Source: https://www.prnewswire.com/news-releases/assort-health-raises-120-million-series-c-to-scale-largest-deployment-of-ai-agents-for-the-patient-journey-302808634.html